The application of povidone in the preparation of modified release tablets

1. Abdelbary A., Elshafeey A.H, Zidan G.: Comparative effects of different cellulosic based directly compressed orodispersable tablets on oral bioavailability of famotidine. Carbohydr. Polym., 77, 799, 2009.Search in Google Scholar

2. Abed K.K. et al.: Formulation and optimization of orodispersible tablets of diazepam. AAPS PharmSciTech., 11(1), 356, 2010.10.1208/s12249-010-9387-y285047820232267Search in Google Scholar

3. Akbari J. et al.: Influence of hydroxypropyl methylcellulose molecular weight grade on water uptake, erosion and drug release properties of diclofenac sodium matrix tablets. Trop. J. Pharm. Res., 10(5), 535, 2011.10.4314/tjpr.v10i5.1Search in Google Scholar

4. Alves L.D. et al.: Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydr. Polym., 104, 166, 2014.10.1016/j.carbpol.2014.01.02724607174Search in Google Scholar

5. Al-Zoubi N. et al.: Sustained release of diltiazem HCl tableted after co-spray drying and physical mixing with PVAc and PVP. Drug Dev. Ind. Pharm., 2, 1, 2015.10.3109/03639045.2015.104784826035331Search in Google Scholar

6. Attama A.A., Adikwu M.U., Nnamani P.O.: Delivery of diclofenac sodium via non-disintegrating bioadhesive tablets of paraffin wax. S T P Pharma. Sci., 13, 147, 2003.Search in Google Scholar

7. Avachat A., Kotwal V.: Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech., 19, 8(4), E88, 2007.10.1208/pt0804088275055818181548Search in Google Scholar

8. Bourne D.W., Banker G.S., Rhodes C.T. (2002). Modern pharmaceutics 4th ed. New York: Marcel Dekker Inc.; p.67.Search in Google Scholar

9. Cong W. et al.: Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs. Eur. J. Drug Metab. Pharmacokinet., 39, 203, 2014.10.1007/s13318-013-0150-024061692Search in Google Scholar

10. Costa P., Lobo J.M.: Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 13, 123, 2001.Search in Google Scholar

11. Desai C., Prabhakar B.: Development and evaluation of orally disintegrating tablets of cilostazol-β-CD inclusion complexes. Drug Dev. Ind. Pharm., 28, 1, 2014.Search in Google Scholar

12. Desai P.M. et al.: Functionality of disintegrants and their mixtures in enabling fast disintegration of tablets by a quality by design approach. AAPS PharmSciTech., 15(5), 1093, 2014.10.1208/s12249-014-0137-4417965024848762Search in Google Scholar

13. Draganoiu E., Andheria M., Sakr A.: Effect of Kollidon^® SR on the release of Albuterol Sulphate from matrix tablets. Saudi Pharm. J., 19(1), 19, 2011.10.1016/j.jsps.2010.11.002379263224115901Search in Google Scholar

14. Elwerfalli A.M. et al.: New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook. Curr. Drug Deliv., Mar 10 [Epub ahead of print], 2015.10.2174/156720181266615031015123825760951Search in Google Scholar

15. European Pharmacopeia 8.0. Strasbourg: Council of Europe (2014); pp.285, 288,298, 2962, 3078.Search in Google Scholar

16. Fini A. et al.: Fast dispersible/slow releasing ibuprofen tablets. Eur. J. Pharm. Biopharm., 69(1), 335, 2008.10.1016/j.ejpb.2007.11.01118182280Search in Google Scholar

17. Gohel M.C., Jogani P.D.: A review of co-processed directly compressible excipients. J. Pharm. Pharmaceut. Sci., 8, 76, 2005.Search in Google Scholar

18. Gohel M. et al.: Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech., 26, 5(3), e36, 2004.10.1208/pt050336Search in Google Scholar

19. Grund J. et al.: The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets. Int. J. Pharm., 469, 94, 2014.10.1016/j.ijpharm.2014.04.033Search in Google Scholar

20. Hadjiioannou T.P., Christian G.D., Koupparis M.A. (1993). Quantitative calculations in pharmaceutical practice and research. New York: VCH Publishers Inc.; p:345.Search in Google Scholar

21. Higuchi T.: Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci., 52, 1145, 1963.10.1002/jps.2600521210Search in Google Scholar

22. Katsuno E. et al: Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability. Powder Tech., 241, 60, 2013.10.1016/j.powtec.2013.03.008Search in Google Scholar

23. Kranz H., Wagner T.: Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations. Eur. J. Pharm. Biopharm., 62 70, 2006.10.1016/j.ejpb.2005.07.003Search in Google Scholar

24. Kurkov S.V., Loftsson T.: Cyclodextrins. Int. J. Pharm., 30, 453(1), 167, 2013.10.1016/j.ijpharm.2012.06.055Search in Google Scholar

25. Late S.G., Banga A.K.: Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent. AAPS PharmSciTech., 11(4), 1627, 2010.10.1208/s12249-010-9541-6Search in Google Scholar

26. Martindale: The complete drug reference (Accessed 01.06.2015). London: The Pharmaceutical Press, online: http://www.micromedexsolutions.com/home/dispatch.Search in Google Scholar

27. Mishra D.N. et al.: Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem. Pharm. Bull., 54, 99, 2006.10.1248/cpb.54.99Search in Google Scholar

28. Miyajima M. et al.: Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix. J. Control. Release., 56, 85, 1998.10.1016/S0168-3659(98)00076-5Search in Google Scholar

29. Muñoz H. et al.: Obtaining fast dissolving disintegrating tablets with different doses of melatonin. Int. J. Pharm., 467(1-2), 84, 2014.10.1016/j.ijpharm.2014.03.05424699354Search in Google Scholar

30. Pabari R.M., Ramtoola Z.: Application of face-centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. Int. J. Pharm., 430(1-2), 18, 2012.10.1016/j.ijpharm.2012.03.021Search in Google Scholar

31. Polish Pharmacopoeia X (2014). Warsaw: The Polish Pharmaceutical Society, pp: 388, 392, 395, 396, 443, 444, 3423, 3528.Search in Google Scholar

32. Sahoo J. et al.: Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose. AAPS Pharm. Sci. Tech., 9, 577, 2008.10.1208/s12249-008-9092-2Search in Google Scholar

33. Siepmann F. et al.: Modeling drug release from PVAc/PVP matrix tablets. J. Control. Release., 141, 216, 2010.10.1016/j.jconrel.2009.08.027Search in Google Scholar

34. Siepmann J., Peppas N.A.: Modeling of drug release from delivery system based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliver. Rev., 48, 139, 2001.Search in Google Scholar

35. Strübing S., Metz H., Mäder K.: Characterization of poly(vinyl acetate) based floating matrix tablets. J. Control. Release, 126, 149, 2008.Search in Google Scholar

36. Su S.F. et al.: In vitro and in vivo comparison of two diclofenac sodium sustained release oral formulations. Int. J. Pharm., 260(1), 39, 2003.10.1016/S0378-5173(03)00237-0Search in Google Scholar

37. Wiranidchapong C. et al.: Plasticizing effect of ibuprofen induced an alteration of drug released from Kollidon SR matrices produced by direct compression. Drug Dev. Ind. Pharm., 41, 1037, 2015.10.3109/03639045.2014.92591724918171Search in Google Scholar

38. Yekpe K. et al.: Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging. Int. J. Pharm., 486, 242, 2015.10.1016/j.ijpharm.2015.03.06025835268Search in Google Scholar

39. Zimmer Ł., Kasperek R., Poleszak E.: Modern polymers in matrix tablets technology. Polim. Med., 44(3), 189, 2014.Search in Google Scholar